Growth suppression induced by antitumor drug vitamin K-3 in human hepatoma HepG2 cells is accompanied by downregulation of proliferating cell nuclear antigen expression.
The effects of VK3 on the expression of proliferating cell nuclear antigen (PCNA) and tumor suppresser p53 were investigated in human hepatoma HEPG2 cells. VK3 (50-250 mu M) for 3 h-treatment, induced 2- to 5-fold increase in PCNA mRNA. Cells treated with 100 mu M of VK3 for 0-8 h, showed PCNA mRNA initially increased but subsequently decreased. PCNA protein decreased in 75-100 mu M VK3-treated asynchronous cells but decreased slightly in 100 mu M VK3-treated synchronized cells. p53 protein increased 2-fold in VK3-treated synchronized cells. No changes in PCNA were noted with coincubation of VK3 and actinomycin D, alpha-amanitin, or cycloheximide. This evidence shows that VK3-induced cell growth inhibition and cell cycling events are accompanied by down-regulation of PCNA protein expression.